Education
About Us
Working with TipRanks
Follow Us
Inozyme Pharma (INZY)
NASDAQ:INZY
Inozyme Pharma (INZY) Ownership Overview
3.22% Insiders
8.94% Mutual Funds
48.40% Other Institutional Investors
8.37% ETFs
31.08% Public Companies and Individual Investors
The ownership structure of Inozyme Pharma (INZY) stock is a mix of institutional, retail, and individual investors. Approximately 65.70% of the company’s stock is owned by Institutional Investors, 3.22% is owned by Insiders, and 31.08% is owned by Public Companies and Individual Investors.
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Mar 31, 2025 | xxxxxxxxxxxxx | $913402 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,663,530 | Institution | 4.13% | 10,627,485 | |
| 2,367,454 | Institution | 3.67% | 9,446,141 | |
| 2,344,694 | Institution | 3.63% | 9,355,329 | |
| 1,571,741 | Insider | 2.43% | 6,271,247 | |
| 1,165,442 | Institution | 1.81% | 4,650,114 | |
| 1,003,739 | Institution | 1.55% | 4,004,919 | |
| 588,557 | Institution | 0.91% | 2,348,342 | |
| 469,060 | Institution | 0.73% | 1,871,549 | |
| 423,926 | Insider | 0.66% | 1,691,465 | |
| 276,007 | Institution | 0.43% | 1,101,268 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,367,454 | Institution | 3.67% | 9,446,141 | |
| 1,165,442 | Institution | 1.81% | 4,650,114 | |
| 588,557 | Institution | 0.91% | 2,348,342 | |
| 469,060 | Institution | 0.73% | 1,871,549 | |
| 276,007 | Institution | 0.43% | 1,101,268 | |
| 270,288 | Institution | 0.42% | 1,078,449 | |
| 160,868 | Institution | 0.25% | 641,863 | |
| 143,158 | Institution | 0.22% | 571,200 | |
| 93,000 | Institution | 0.14% | 371,070 | |
| 47,229 | Institution | 0.07% | 188,444 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,687,803 | Institution | 2.61% | 1,940,973 | |
| 1,292,784 | Institution | 2.00% | 5,158,208 | |
| 679,651 | Institution | 1.05% | 781,599 | |
| 448,229 | Institution | 0.69% | 1,788,434 | |
| 256,172 | Institution | 0.40% | 294,598 | |
| 244,011 | Institution | 0.38% | 973,604 | |
| 199,176 | Institution | 0.31% | 794,712 | |
| 169,439 | Institution | 0.26% | 676,062 | |
| 108,751 | Institution | 0.17% | 433,916 | |
| 35,411 | Institution | 0.05% | 40,723 |
FAQ
Who Owns Inozyme Pharma (INZY)?
According to the latest TipRanks data, approximately 48.40% of the company's stock is held by institutional investors, 3.22% is held by insiders, and 31.08% is held by retail investors.
What percentage of Inozyme Pharma (INZY) stock is held by institutional investors?
According to the latest TipRanks data, approximately 48.40% of Inozyme Pharma (INZY) stock is held by institutional investors.
What percentage of Inozyme Pharma (INZY) stock is held by retail investors?
According to the latest TipRanks data, approximately 31.08% of Inozyme Pharma (INZY) stock is held by retail investors.
Who owns the most shares of Inozyme Pharma (INZY)?
Vanguard owns the most shares of Inozyme Pharma (INZY).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.